References [i] Martinez, M., & Thompson, H
Therapeutic drug monitoring is not required or available for most anticonvulsants
Potential side effects may include: Water retention Joint pain Numbness or tingling Insulin resistance Headaches Hormonal imbalances Injection site reactions More serious concerns include: Long-term cancer risk (due to IGF-1 stimulation) Endocrine disruption Unknown contamination in unregulated products Additionally, many peptides are banned by sports organizations, such as the World Anti-Doping Agency
Beyond the obvious fact that one type of weight loss drug you self-inject and the other you swallow, timing is also important when taking an oral medication, more of which well cover in how and when to take it
All these studies have proven cardiovascular safety for the respective DPP-4 inhibitors
PLIP 2021: expanding the scope of the proteinligand interaction profiler to DNA and RNA